Combination effect of equol and TRAIL against human cervical cancer cells

Anticancer Research

Volumn 33, Issue 3, 2013, Pages 903-912

  Kim, Eun Young ^a   Kim, An Keun ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

Apoptosis; Caspases; Cervical cancer cells; Death receptors; Equol; TRAIL

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; DAIDZEIN; DEATH RECEPTOR 4; DEATH RECEPTOR 5; EQUOL; FC RECEPTOR; GENISTEIN; PROTEIN BID; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL SURFACE; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; UTERINE CERVIX CANCER; WESTERN BLOTTING;

APOPTOSIS; CASPASES; EQUOL; HELA CELLS; HUMANS; RECEPTORS, DEATH DOMAIN; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84875876070     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Akinyemiju TF: Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the World Health Survey. PLoS One 7: e48834, 2012.
2. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJL and Naghavi M: Breast and cervical cancer in 187 countries between 1980 and 2010: A systematic analysis. Lancet 378: 1461-1484, 2011.
3. Zolciak-Siwinska A, Jonska-Gmyrek J and Socha J: Recurrent cervical cancer-therapeutic options. Ginekol Pol 83: 527-531, 2012.
4. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall RH: Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104: 155-162, 1999.
5. Wang S and El-Deiry WS: TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 22: 8628-8633, 2003.
6. Shankar S and Srivastava RK: Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: Mechanisms and clinical implications. Drug Resist Update 7: 139-156, 2004.
7. Im SR and Jang YJ: Aspirin enhances TRAIL-induced apoptosis via regulation of ERK1/2 activation in human cervical cancer cells. Biochem Bioph Res Co 424: 65-70, 2012.
8. Kruyt FAE: TRAIL and cancer therapy. Cancer Lett 263: 14-25, 2008.
9. Marini P and Belka C: Death receptor ligands: New strategies for combined treatment with ionizing radiation. Curr Med Chem Anticancer Agents 3: 334-342, 2003.
10. Jacquemin G, Shirley S and Micheau O: Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: A promising approach to kill resistant cancer cells? Cell Mol Life Sci 67: 3115-3130, 2010.
11. Singh M, Singh P and Shukla Y: New strategies in cancer chemoprevention by phytochemicals. Front Biosci 4: 426-452, 2012.
12. Barnes S: The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Res Tr 46: 169-179, 1997.
13. Kumar NB, Cantor A, Allen K, Riccardi D, Besterman-Dahan K, Seigne J, Helal M, Salup R and Pow-Sang J: The specific role of isoflavones in reducing prostate cancer risk. Prostate 59: 141-147, 2004.
14. Sarkar FH and Li Y: The role of isoflavones in cancer chemoprevention. Front Biosci 9: 2714-2724, 2004.
15. Choi EJ and Kim GH: Daidzein causes cell cycle arrest at the G 1 and G2/M phases in human breast cancer MCF-7 and MDAMB-453 cells. Phytomedicine 15: 683-690, 2008.
16. Rabiau N, Kossai M, Braud M, Chalabi N, Satih S, Bignon YJ and Bernard-Gallon DJ: Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by polymerase chain reaction arrays in human prostate cancer cell lines. Cancer Epidemiol 34: 200-206, 2010.
17. Shi J, Ji A, Cao Z, Cao R, Li D, Yang R and Wang F: Equol induced apoptosis of human breast cancer MDA-MB-231 cell by inhibiting the expression of nuclear factor-kappaB. Wei Sheng Yan Jiu 40: 95-98, 2011.
18. Choi EJ and Kim GH: Anticancer mechanism of equol in 7,12- dimethylbenz(a)anthracene-treated animals. Int J Oncol 39: 747-754, 2011.
19. Ashkenazi A, Holland P and Eckhardt SG: Ligand-based targeting of apoptosis in cancer: The potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL). J Clin Oncol 26: 3621-3630, 2008.
20. Pan MH and Ho CT: Chemopreventive effects of natural dietary compounds on cancer development. Chem Soc Rev 37: 2558-2574, 2008.
21. Galati G and O'Brien PJ: Potential toxicity of flavonoids and other dietary phenolics: Significance for their chemopreventive and anticancer properties. Free Radical Bio Med 37: 287-303, 2004.
22. Ramos S: Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways. Mol Nutr Food Res 52: 507-526, 2008.
23. Jung YH, Heo J, Lee YJ, Kwon TK and Kim YH: Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5. Life Sci 86: 351-357, 2010.
24. Shankar S, Ganapathy S, Chen Q and Srivastava RK: Curcumin sensitizes TRAIL-resistant xenografts: Molecular mechanisms of apoptosis, metastasis and angiogenesis. Mol Cancer 7: 16-31, 2008.
25. Shankar S, Chen Q, Siddiqui I, Sarva K and Srivastava RK: Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3,4',5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential. J Mol Signal 2: 7-23, 2007.
26. Bousserouel S, Bour G, Kauntz H, Gosse F, Marescaux J and Raul F: Silibinin inhibits tumor growth in a murine orthotopic hepatocarcinoma model and activates the TRAIL apoptotic signaling pathway. Anticancer Res 32: 2455-2462, 2012.
27. Nozawa F, Itami A, Saruc M, Kim M, Standop J, Picha KS, Cowan KH and Pour PM: The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth. Pancreas 29: 45-52, 2004.
28. Jin CY, Park C, Cheong J, Choi BT, Lee TH, Lee JD, Lee WH, Kim GY, Ryu CH and Choi YH: Genistein sensitizes TRAILresistant human gastric adenocarcinoma AGS cells through activation of caspase-3. Cancer Lett 257: 56-64, 2007.
29. Siegelin MD, Siegelin Y, Habel A and Gaiser T: Genistein enhances proteasomal degradation of the short isoform of FLIP in malignant glioma cells and thereby augments TRAILmediated apoptosis. Neurosci Lett 453: 92-97, 2009.
30. Jin CY, Park C, Moon SK, Kim GY, Kwon TK, Lee SJ, Kim WJ and Choi YH: Genistein sensitizes human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by enhancing BID cleavage. Anticancer Drug 20: 713-722, 2009.
31. Siegelin MD, Gaiser T, Habel A and Siegelin Y: Daidzein overcomes TRAIL-resistance in malignant glioma cells by modulating the expression of the intrinsic apoptotic inhibitor, Bcl-2. Neurosci Lett 454: 223-228, 2009.
32. Riedl SJ and Shi Y: Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Bio 5: 897-907, 2004.
33. Thorburn A: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway signaling. J Thorac Oncol 2: 461-465, 2007.
34. Li H, Zhu H, Xu CJ and Yuan J: Cleavage of BID by caspase-8 mediates the mitochondrial damage in the FAS pathway of apoptosis. Cell 94: 491-501, 1998.
35. Kouhara J, Yoshida T, Nakata S, Horinaka M, Wakada M, Ueda Y, Yamagishi H and Sakai T: Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines. Int J Oncol 30: 679-687, 2007.
36. Park C, Jin CY, Hwang HJ, Kim GY, Jung JH, Kim WJ, Yoo YH and Choi YH: J7, a methyl jasmonate derivative, enhances TRAIL-mediated apoptosis through up-regulation of reactive oxygen species generation in human hepatoma HepG2 cells. Toxicol In Vitro 26: 86-93, 2012.
37. Szliszka E and Krol W: Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells. Oncol Rep 26: 533-541, 2011.
38. Yodkeeree S, Sung B, Limtrakul P and Aggarwal BB: Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: Evidence for an essential role of reactive oxygen species. Cancer Res 69: 6581-6589, 2009.
39. Sung B, Ravindran J, Prasad S, Pandey MK and Aggarwal BB: Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL. J Biol Chem 285: 35418-35427, 2010.
40. Huong le D, Shim JH, Choi KH, Shin JA, Choi ES, Kim HS, Lee SJ, Kim SJ, Cho NP and Cho SD: Effect of beta-phenylethyl isothiocyanate from cruciferous vegetables on growth inhibition and apoptosis of cervical cancer cells through the induction of death receptors 4 and 5. J Agr Food Chem 59: 8124-8131, 2011.